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Endoplasmic reticulum stress is a proapoptotic and proﬁbrotic stimulus. Ablation of C/EBP homologous
protein (CHOP) is reported to reverse cardiac dysfunction by attenuating cardiac endoplasmic reticulum
stress in mice with pressure overload or ischemia/reperfusion, but it is unclear whether loss of CHOP also
inhibits cardiac remodeling induced by permanent-infarction. In mice with permanent ligation of left
coronary artery, we found that ablation of CHOP increased the acute phase mortality. For the mice
survived to 4 weeks, left ventricular anterior (LV) wall thickness was larger in CHOP knockout mice than
in the wildtype littermates, while no difference was noted on posterior wall thickness, LV dimensions, LV
fractional shortening and ejection fraction. Similarly, invasive assessment of LV hemodynamics,
morphological analysis of heart and lung weight indexes, myocardial ﬁbrosis and TUNEL-assessed
apoptosis showed no signiﬁcant differences between CHOP knockout mice and their wildtype ones,
while in mice with ischemia for 45 min and reperfusion for 1 week, myocardial ﬁbrosis and apoptosis in
the infarct area were signiﬁcantly attenuated in CHOP knockout mice. These ﬁndings indicate that
ablation of CHOP doesn't ameliorate cardiac remodeling induced by permanent-myocardial infarction,
which implicates that early reperfusion is a prerequisite for ischemic myocardium to beneﬁt from CHOP
inhibition.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Myocardial infarction (MI) is a leading cause of morbidity and
mortality of coronary heart disease. Early reperfusion therapy
including thrombolysis and primary percutaneous coronary inter-
vention is the most practical and widely practiced approach for
myocardial infarction [1]. For MI patients who have no opportunity
to receive reperfusion therapy, attenuating post-infarction cardiac
remodeling is a reasonable strategy.
Myocardial apoptosis and ﬁbrosis greatly contribute to cardiac
remodeling and dysfunction [2e7]. Endoplasmic reticulum (ER)
stress has been demonstrated to be closely associated with
apoptosis [2] and ﬁbrosis [8,9]. ER stress is prolonged and, Nanfang Hospital, Southern
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Inc. This is an open access article uaggravated in hearts subjected to pressure overload, ischemia/
reperfusion injury or MI, whereas CHOP is up-regulated and con-
tributes to cardiac dysfunction. Ablation of CHOP can attenuate
cardiac ER stress in mice subjected to pressure overload [2], and
alleviate myocardial reperfusion injury by inhibiting myocardial
apoptosis and inﬂammation [10]. However, the role of CHOP deﬁ-
ciency in the heart suffering from MI without reperfusion remains
unknown. Considering the clues aforementioned, we hypothesized
that CHOP ablation would inhibit post-MI cardiac remodeling.
1. Materials and methods
1.1. MI and myocardial ischemia/reperfusion models
All procedures were performed in accordance with our institu-
tional guidelines for animals for the Care and Use of Laboratory
Animals (NIH Publication No. 85e23, revised 1996). Mice were kept
at standard housing conditions with a light/dark cycle of 12 h andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Effects of C/EBP homologous protein (CHOP) deletion on survival of myocardial infarction (MI) mice. (A) Cumulated survival rate of CHOP knockout (KO) and wildtype (WT)
mice in response to MI, insert picture indicates PCR results of genotyping. (B) Electrocardiogram before and after left coronary artery ligation. After ligation, the ST segment was
signiﬁcantly elevated, which was the sign of success of the MI surgery. (C) Examples of autopsy pictures from a dead mouse. Obvious rupture slits in the left ventricle free wall were
identiﬁed. (D) Examples of TTC (triphenyltetrazolium chloride) stain in heart slices and myocardial infarct size (IS) (relative to left ventricular area (LV)) after MI for 24 h, n ¼ 5 in
each group, scale bar, 2 mm.
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mates were used for the experimental study. Heterozygous CHOP
mice (purchased from the Jackson Laboratory) were intercrossed at
our animal facility to obtain homozygous mice. Mice (aged 8e12
weeks, weighing 20e25 g) were used to generate MI and myocar-
dial ischemia/reperfusion (IR) models by left coronary artery liga-
tion as described elsewhere [3]. In brief, mice were anaesthetized
with a mixture of xylazine (5 mg kg1, ip) and ketamine
(100 mg kg1, ip), and the depth of anesthesia was assessed by
monitoring the pedal withdrawal reﬂex. Mice were then ventilated
and subjected to a left-sided thoracotomy and the left coronary
artery ligation to induce MI with subsequent development of heart
failure. For IR model, after 45 min of coronary occlusion, the liga-
ture was removed and the heart was reperfused for 24 h or 1 week.
Ischemia was judged by myocardial blanching and electrocardio-
gram ST-segment elevation. Sham operated mice underwent the
same procedure without ligation of left coronary artery. The sur-
vival of mice was checked out twice a day to ensure that once adead mouse is found, autopsy should be performed immediately to
conﬁrm the reason of death. Four weeks after surgery, the mice
were sacriﬁced by overdose anesthesia with pentobarbital sodium
(150 mg kg1, ip) and cervical dislocation, and their hearts and
lungs were extracted for calculation of heart weight to body weight
ratio (HW/BW) and lung weight to BW ratio (LW/BW) as well as
histological examinations.
1.2. Echocardiographic measurements
Both left ventricular (LV) dimensions and function were evalu-
ated by using echocardiography (a Sequoia 512 systemwith a 15L-8
probe, Siemens, Munich, Germany) at 4 weeks after surgery [5].
Mice were ﬁxed inwaking state to avoid the inﬂuence of anesthesia
on the parameter measurements. Two-dimensional echocardio-
graphic views of the mid-ventricular short axis were obtained at
the level of the papillary muscle tips below the mitral valve. From
M-mode tracings, LV anterior and posterior wall thickness at
Fig. 2. Effect of CHOP deletion on echocardiographic cardiac remodeling and left ventricular hemodynamic at 4 weeks after myocardial infarction. (A) Left ventricular anterior and
posterior wall thickness at end-diastolic stage (LVAWd and LVPWd). (B) Left ventricular end-diastolic diameter (LVEDd) and end-systolic diameter (LVESd). (C) Left ventricular
fractional shortening (LVFS) and ejection fraction (LVEF). (D) Left ventricular systolic pressure (LVSP). The insert shows example of carotid arterial and left ventricular pressure curve
recording. (E) Left ventricular end-diastolic pressure (LVEDP). (F) Maximum rates of left ventricular rising and descending (dp/dt max, dp/dt min). (G) Left ventricular contractility.
(H) The exponential time constant of left ventricular relaxation (t). #P < 0.05 vs. wildtype MI group (WT MI), *P < 0.05 versus the corresponding sham group; n ¼ 6 in each group.
CHOP, C/EBP homologous protein; MI, myocardial infarction; KO, knockout; WT, wildtype.
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(LVEDd) and LV end-systolic diameter (LVESd) were measured,
while LV shortening (LVFS) and ejection fraction (LVEF) were
calculated by the following equations: LVFS ¼ (LVEDd  LVESd)/
LVEDd  100. LVEF ¼ [(LV end-diastolic volume  LV systolic vol-
ume)/LV end-diastolic volume]  100.1.3. Invasive assessment of hemodynamics
LV hemodynamics was evaluated before sacriﬁce of the animals
as described elsewhere [7]. Brieﬂy, mice from each group were
anesthetized with a combination of xylazine and ketamine (light
anesthesia for MI mice), and were ventilated. A Millar catheter was
inserted via the right carotid artery and carefully introduced into
the LV tomeasure the heart rate (HR), systolic pressure (LVSP), end-
diastolic pressure (LVEDP), maximum and minimum rates ofchange in the LV pressure (dp/dt max and dp/dt min, respectively).
Both the contractility index (max dp/dt divided by the pressure at
the time of max dp/dt) and the exponential time constant of
relaxation (t) were calculated using a software program (Blood
Pressure Module).1.4. Histological examinations and apoptosis assay
Myocardial infarct size was determined by using TTC (triphe-
nyltetrazolium chloride) staining. Myocardial ﬁbrosis as well as old
myocardial infarct size was stained with Masson's trichrome.
Apoptosis in myocardium was determined with TUNEL assay by
using an In situ cell death Detection kit, TMR red (Roche,
Switzerland). The positive rate of TUNEL-labeled nuclei was
calculated from four different and randomly selected areas under
confocal microscopy.
Fig. 3. Effect of CHOP knockout on cardiac morphology. (A) Heart weight/body weight (HW/BW) and lung weight/body weight (LW/BW) ratios in response to sham or myocardial
infarction (MI) for 4 weeks. (B) Masson stained old MI size in response to sham or MI for 4 weeks, the insert ﬁgures show the representative pictures of cross section slice of heart
(5) and magniﬁed infarct area (50). (C) Fibrosis in remote area after MI for 4 weeks, the insert ﬁgures show the representative pictures of magniﬁed remote area (100). (D)
Examples of TTC (triphenyltetrazolium chloride) stain in heart slices and myocardial infarct size (IS) (relative to left ventricular area (LV)) after ischemia for 45 min and reperfusion
for 24 h, scale bar, 2 mm. (E) Percent ﬁbrosis in both infarct and remote area of mice subjected to ischemia for 45 min and reperfusion for 1 week, the insert ﬁgures show the
representative pictures of cross section slice of heart (5) and magniﬁed infarct area (100) and remote area (100). *P < 0.05 versus the corresponding sham or wildtype group;
n ¼ 5e6 in each group. CHOP, C/EBP homologous protein; MI, myocardial infarction; KO, knockout; WT, wildtype.
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Statistical signiﬁcance was calculated using SPSS16.0. Numerical
data were expressed as mean ± standard error of mean. Statistical
differences were analyzed using Student's unpaired t-test. The
overall survival of MI mice for 4 weeks was evaluated using
KaplaneMeier survival analysis and groups were compared by log-
rank test. P values lower than 0.05 were considered to be statisti-
cally signiﬁcant.
2. Results
2.1. Ablation of CHOP increased MI-induced mortality
We found that the overall mortality of CHOP knockout mice
with MI was signiﬁcantly higher than in wildtype group (68% vs
38.5%, P < 0.05; Fig. 1A). Most of them died in the ﬁrst week. There
was clear ST segment elevation after left coronary artery ligation inall the MI mice introduced into the research (Fig. 1B). Autopsy on
dead mice showed that cardiac rupture was the principal cause of
death during the ﬁrst 10 days of MI (Fig. 1C). The myocardial infarct
size afterMI for 24 hwas similar between CHOP knockout mice and
wildtype ones (Fig. 1D). No death occurred in both wildtype and
CHOP knockout mice subjected to ischemia for 45 min and reper-
fusion for 1 week. These results indicate that ablation of CHOP
increased post-MI rupture in mice without prompt reperfusion.
2.2. Ablation of CHOP didn't attenuate post-MI cardiac remodeling
and LV dysfunction
Four weeks after MI, no signiﬁcant differences were noted on LV
diameter and systolic function except that LVAWd (infarcted wall)
was signiﬁcantly thicker in CHOP knockout MI mice than in wild-
type ones (Fig. 2A). When compared with the corresponding sham
group, it was similar to wildtype mice that CHOP knockout mice
with MI showed enlarged left ventricle (increased LVESd and
Fig. 4. Effect of CHOP knockout on cardiomyocyte apoptosis determined by TUNEL assay. (A) Representative pictures of apoptosis in the infarct area. (B) Quantitation of apoptosis in
the infarct area of heart with myocardial infarction (MI) or myocardial ischemia for 45 min and reperfusion for 1 week. *P < 0.05 versus the wildtype group. KO, knockout; WT,
wildtype; IR, ischemia/reperfusion.
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revealed that deﬁciency of CHOP can't signiﬁcantly ameliorate
post-MI cardiac remodeling.
2.3. Ablation of CHOP didn't improve post-MI left ventricular
hemodynamic
The LV hemodynamic assessment showed that MI for 4 weeks
resulted in a signiﬁcant reduction of LVSP, max dp/dt, min dp/dt, and
contractility as well as a signiﬁcant increase of LVEDP and t when
comparedwith the corresponding shamgroups, but ablation of CHOP
didn't exert signiﬁcant inﬂuences on those indexes (Fig. 2DeH).
2.4. Ablation of CHOP didn't change cardiac morphology and
apoptosis after permanent ischemia
At 4 weeks after MI, both CHOP knockout mice and their wild-
type littermates exhibited increased heart weight to body weightratio (HW/BW). However, there was no signiﬁcant difference on
HW/BW, LW/BW, old myocardial infarct size (ﬁbrosis) and
myocardial ﬁbrosis in the remote area between CHOP knockout
mice and wildtype ones (Fig. 3AeC). In mice with ischemia for
45 min and reperfusion for 24 h, myocardial infarct size was
signiﬁcantly smaller in CHOP knockout mice than in their wildtype
littermates (Fig. 3D). Fibrosis was checked 1 week after reperfusion.
We noted that ﬁbrosis in the infarct area was signiﬁcantly less in
CHOP knockout mice than in wildtype ones, while it was similar in
the remote area (Fig. 3E). These results suggest that ablation of
CHOP fails to reverse cardiac remodeling in mice after MI without
early reperfusion therapy.
After MI for 4 weeks, the infarct area was replaced by ﬁbrotic
scar tissues, and apoptosis in this area was similar between CHOP
knockout mice and wildtype ones (Fig. 4A and B). In response to
ischemia for 45 min and reperfusion for 1 week, apoptosis in the
infarct area was signiﬁcantly less in CHOP knockout mice than in
wildtype ones (Fig. 4A and B).
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The endoplasmic reticulum, an organelle that participates in
folding of secretory and membrane proteins, plays an important
role in regulating apoptosis [11]. CHOP is an ER stress-associated
transcription factor that can either promote expression of pro-
apoptotic factors or suppress anti-apoptotic gene transcription
and is also a proﬁbrotic factor [9,12]. Previous studies have
demonstrated that myocardial apoptosis and ﬁbrosis were
attenuated in CHOP-deﬁcient mice subjected to pressure over-
load or ischemia/reperfusion [2,10]. Both ﬁbrosis and apoptosis
are important factors inﬂuencing post-MI cardiac rupture
[13,14]. It seems that ablation of CHOP should produce inhibi-
tory effects on myocardial apoptosis and ﬁbrosis in mice with
MI, then how to explain our ﬁnding in this study that CHOP
deﬁciency resulted in more post-MI rupture? Although inhibi-
tion of apoptosis was reported to be able to prevent cardiac
rupture [15], simultaneous inhibition of ﬁbrosis would be
detrimental for cardiac healing because recruitment of activated
ﬁbroblasts is necessary for prevention of post-MI rupture [14].
Loss of the proﬁbrotic ability of CHOP in CHOP knockout mice
might be the leading cause of higher incidence of post-MI
rupture.
Accumulated evidence has indicated that myocardial ischemia/
reperfusion or MI or pressure overload can induce the up-
regulation of CHOP and then lead to ER stress-mediated apoptosis
and cardiac dysfunction [2,11,16], while pharmacological in-
terventions and genetic approaches for inhibiting the expression of
CHOP can attenuate cardiac remodeling in animals subjected to
pressure overload or myocardial ischemia/reperfusion [10,11,17,18].
These lines of evidence suggest that CHOP deﬁciency should also be
beneﬁcial for post-MI cardiac remodeling mediated by inhibition of
apoptosis and ﬁbrosis in human or animals with MI but without
receiving prompt reperfusion therapy. Unexpectedly, we noted that
neither the morphological remodeling nor functional deterioration
in mice with permanent coronary ligation could be prevented by
deletion of CHOP. Our ﬁndings support the idea that early reper-
fusion treatment is a prerequisite to obtain beneﬁt from CHOP in-
hibition inMI heart. In clinical practice, there has been an increased
emphasis on ensuring timely access of patients to percutaneous
coronary intervention.
It is well-known that unrelieved ischemia (usually longer than
6 h in human) would cause complete damage to the myocardium
previously supplied by the occluded artery. Permanent ischemia-
destroyed myocardium is replaced by ﬁbrous scar tissue and
ﬁnally develops to progressive chronic heart failure. It is a
consensus that “time is muscle”, thus timely reperfusion is the
standard treatment for acute MI so as to salvage jeopardized
ischemic but still viable myocardium and prevent or slow the car-
diac remodeling. Drugs or genetic manipulations slowing the pro-
gression of ischemic damage should limit infarct size if timely
reperfusion is guaranteed. Effects of b-blockers on ST-elevation MI
patients without undergoing reperfusion were widely evaluated in
many clinical trials, but no clear reduction in infarct size was
detected [19], in agreement with our ﬁndings in this study that
ablation of pro-ﬁbrotic and pro-apoptotic CHOP didn't attenuate
permanent MI-induced cardiac remodeling. Emerging evidence is
supporting the idea that early reperfusion treatment is a prereq-
uisite to obtain beneﬁt from pharmacological or genetic in-
terventions because the chances of myocardium salvage are
negligible without prompt reperfusion, lending to explain why
CHOP deﬁciency is beneﬁcial for myocardial ischemia/reperfusion
injury but not chronic MI.
In conclusion, although inhibition of CHOP is known to exert
anti-apoptotic and anti-ﬁbrotic effects in heart, deletion of CHOPincreases the incidence of post-MI cardiac rupture and doesn't
prevent cardiac remodeling in the case of permanent coronary
ligation without early reperfusion.Funding
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